Brandon Lau

Brandon Lau, MBA, CEL, FMVA, IMAA, currently serves as the Director and Head of Financial Planning & Analysis at Enveda Biosciences, where responsibilities include optimizing financial strategies and developing risk-adjusted net present value valuation models. Previously, Brandon held the position of Director, Head of Strategic Finance & Planning at NextCure, Inc., facilitating the build-out of the FP&A function and leading the strategic planning process. Other notable roles include FP&A Consultant at Catalent Pharma Solutions, where initiatives drove triple-digit revenue growth, and Director, Head of Financial Planning & Analysis at Aeras, managing comprehensive planning processes. Brandon’s earlier experience includes positions at the Export-Import Bank of the United States and United Bankshares, Inc., focusing on commercial lending and portfolio management, along with a managerial role at AstraZeneca overseeing substantial financial planning and budgeting. Education includes a Master of Business Administration from Boston University, a Certification of Executive Leadership from Cornell University, and a Bachelor of Business Administration from Soochow University.